Japan"s Takeda takeover bid causes investor headache

Japan's most prominent activist investor on Wednesday demanded Toshiba Machine Co hold an extraordinary shareholders meeting to discuss its plans to introduce defense measures against a hostile takeover......»»

BlackRock Inc has built a 5.12% stake in Toshiba Machine , a former Toshiba Corp subsidiary that has been targeted by Japan's most prominent activist investor, according to a regulatory filing by the U.S. asset manager......»»

Rare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports......»»

Takeda moved closer to securing a $64 billion takeover of Shire after the target said it was willing to recommend that shareholders accept the Japanese firm’s latest proposal......»»

NEW YORK/LONDON (Reuters) - Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan's Takeda Pharmaceutical , although talks are continuing, while sources said Allergan was also in competing negotiations......»»

LONDON (Reuters) - Shire , the $47 billion rare disease drugmaker being stalked by Japan's Takeda Pharmaceutical , faces fresh criticism over its executive pay policy from a leading investor advisory group as a crunch week approaches......»»

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business.....»»

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceu.....»»

LONDON (Reuters) - Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion......»»

LONDON (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation......»»

It's the largest-ever international takeover by any Japanese company, at a value of $62 billion. Japan’s Takeda Pharmaceutical is about to become.....»»

Reuters J.....»»

Japanese drugmaker Takeda has reached a $62 billion deal to buy rival Shire in the world's biggest takeover so far this year......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

On Thursday, Takeda Pharmaceutical Co. Ltd. said that Japan's Fair Trade Commission has approved its $62 billion bid to acquire the second-largest biotech employer in Massachusetts, Shire Pharmaceuticals plc. According to Reuters, the deal has alre.....»»

The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire , despite some shareholders' fears about the resulting debt burden......»»

Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support......»»

Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal......»»

The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»